Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Background.Advancing age, chronic inflammation, oxidative damage, and disorders of lipid metabolism are positively linked to the late-life cognitive impairment. Serum biomarkers may be associated with the cognitive status in older men.Methods.440 old male subjects with different cognitive functions were recruited to investigate probable serum markers. Pearson Chi-Squared test, univariate analysis, and multivariate logistic regression analysis were performed to evaluate biomarkers which may be associated with cognitive status.Results.Levels of fundus atherosclerosis (AS) (P<0.001), age (P<0.001), serum biomarkers peroxidase (POD) (P=0.026) and interleukin-6 (IL-6) (P=0.001), serum levels of high-density lipoprotein cholesterol (HDL-C) (P<0.001), apolipoprotein A2 (ApoA2) (P=0.001), and ApoC2 (P=0.005) showed significant differences. Compared to group 3, ApoA1 in group 1 (OR = 1.30, 95% CI 1.01–1.67) and group 2 (OR = 1.47, 95% CI 1.11–1.94) were higher, while ApoA2 were lower (group 1: OR = 0.43, 95% CI 0.18–1.02; group 2: OR = 0.21, 95% CI 0.08–0.54) after adjusting for control variables.Conclusion.The results demonstrated that age, AS levels, POD, IL-6, HDL-C, ApoA2, and ApoC2 were significantly related to cognitive status. Moreover, ApoA1 and ApoA2 were independently associated with cognitive impairment and late-life dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cells harboring PSMC5 variants exhibit characteristics reminiscent of senescent or neurodegenerative cells, including impaired mitophagy47, type I IFN response48, abnormal apolipoproteins and/or cholesterol levels49,50, cognitive inflexibility51,52, impaired neuritogenesis53,54, and an imbalanced E/I ratio55,56.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
BackgroundInflammatory markers in population studies of aging
Singh, T., & Newman, A. B. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 863
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review
Eichner, J. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.6.487 · Cited by 796 · cited 1×
“Apolipoproteins are important components of plasma lipoproteins which are synthesized in liver and have been proved to play a significant role in the lipid metabolism and the formation of lipoproteins [36].”
BackgroundLipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
Munoz (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6269 · Cited by 760
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
Inflammatory markers and cognition in well-functioning African-American and white elders
Yaffe, K., Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003) · Neurology · doi:10.1212/01.wnl.0000073620.42047.d7 · Cited by 706 · cited 1×
“The subjects for the study were divided into three groups according to MMSE scores: group 1 (28 ≤ MMSE≤ 30), group 2 (24≤MMSE≤ 27), and group 3 (MMSE ≤ 23).”
BackgroundSerum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum?
Panza, F., Frisardi, V., Capurso, C., D'Introno, A., Colacicco, A. M., Imbimbo, B. P., Santamato, A., Vendemiale, G., Seripa, D., Pilotto, A., et al. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b0fa13 · Cited by 612
Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging
Weaver, J. D., Huang, M.-H., Albert, M., Harris, T., Rowe, J. W., & Seeman, T. E. (2002) · Neurology · doi:10.1212/wnl.59.3.371 · Cited by 536
Research works printed but not linked: 3
- 2011, Collegium Antropologicum, 35, 115
- Journal of Aging Research & Clinical Practice
- 2004, International Journal of Molecular Medicine, 14, 609
Cited by
Svensson, T., Sawada, N., Mimura, M., Nozaki, S., Shikimoto, R., & Tsugane, S. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0336-y · Cited by 88
VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction
Usui, N., Iwata, K., Miyachi, T., Takagai, S., Wakusawa, K., Nara, T., Tsuchiya, K. J., Matsumoto, K., Kurita, D., Kameno, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102917 · Cited by 48
Zhao, B., Shang, S., Li, P., Chen, C., Dang, L., Jiang, Y., Wang, J., Huo, K., Deng, M., Wang, J., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0956-5 · Cited by 47
Effects of Plasma Lipids and Statins on Cognitive Function
Li, R., Wang, T., Lyu, P., Liu, Y., Chen, W., Fan, M., & Xu, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.225062 · Cited by 40
Proteomic Profiling of Seminal Plasma Proteins in Varicocele Patients
Selvam, M. K. P., & Agarwal, A. K. (2019) · The World Journal of Men s Health · doi:10.5534/wjmh.180118 · Cited by 37
Mihelčić, M., Šimić, G., Leko, M. B., Lavrač, N., Džeroski, S., Šmuc, T., & Initiative, A. D. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187364 · Cited by 35
Berezhnoy, G., Laske, C., & Trautwein, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012472 · Cited by 31
Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium
D'Arrigo, J. S. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.12.002 · Cited by 29
Swaminathan, S. K., Zhou, A. L., Ahlschwede, K. M., Curran, G. L., Lowe, V. J., Li, L., & Kandimalla, K. K. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265876 · Cited by 25
Lipoprotein Particles in Cerebrospinal Fluid
Tsujita, M., Melchior, J. T., & Yokoyama, S. (2024) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.123.318284 · Cited by 24
Ya, L., & Lu, Z. (2017) · Medical Science Monitor · doi:10.12659/msm.903636 · Cited by 25
Jiang, L., Jiao, M., Wen, J., Fan, D., Xia, Y., Cao, Y., Shi, R., & Xiao, C. (2020) · Psychogeriatrics · doi:10.1111/psyg.12559 · Cited by 21
Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis
Kothari, V. M., Ho, T. W. W., Cabodevilla, A. G., He, Y., Kramer, F., Shimizu‐Albergine, M., Kanter, J. E., Snell‐Bergeon, J. K., Fisher, E. A. A., Shao, B., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323100 · Cited by 20
Dolci, G., Cruciani, F., Rahaman, M. A., Abrol, A., Chen, J., Fu, Z., Galazzo, I. B., Menegaz, G., Calhoun, V. D., & Initiative, A. D. N. (2025) · Journal of Neural Engineering · doi:10.1088/1741-2552/ae087d · Cited by 24
Rao, W., Zhang, Y., Li, K., & Zhang, X. (2021) · Aging · doi:10.18632/aging.203161 · Cited by 17
Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · BMC Veterinary Research · doi:10.1186/s12917-021-02744-w · Cited by 19
D'Arrigo, J. S. (2017) · Medical Sciences · doi:10.3390/medsci5040029 · Cited by 21
Seminal plasma proteomics as putative biomarkers for male infertility diagnosis
Parvin, A., Erabi, G., Alemi, A., Rezanezhad, A., Maleksabet, A., Sadeghpour, S., Taheri‐Anganeh, M., & Ghasemnejad‐Berenji, H. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119757 · Cited by 16
Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood–Brain Barrier
D'Arrigo, J. S. (2018) · Biomimetics · doi:10.3390/biomimetics3010004 · Cited by 17
Metabolomic analysis of vascular cognitive impairment due to hepatocellular carcinoma
Zhu, D., Zhu, Y., Liu, L., He, X., & Fu, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1109019 · Cited by 14
So, S. W., Nixon, J. P., Bernlohr, D., & Butterick, T. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043381 · Cited by 11
Wu, J., Cao, L., Wang, J., Wang, Y., Hao, H., & Huang, L. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05844-2 · Cited by 9
Custers, E., Vreeken, D., Kleemann, R., Kessels, R. P. C., Smeijers, E. T. O., Mortensen, J. H., Morrison, M. C., Gart, E., Wiesmann, M., Hazebroek, E. J., et al. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08198-5 · Cited by 7
Treating Dementia Early: Limiting Cellular Damage in Brain Tissue
D'Arrigo, J. S. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1902057 · Cited by 9
Küry, S., Stanton, J. E., van Woerden, G., Hsieh, T.-C., Rosenfelt, C., Scott-Boyer, M. P., Most, V., Wang, T., Papendorf, J. J., de Konink, C., et al. (2024) · doi:10.1101/2024.01.13.24301174 · Cited by 6
Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease
Dimitrakopoulos, G. Ν., Vrahatis, A. G., Exarchos, T. P., Krokidis, M. G., & Vlamos, P. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3040045 · Cited by 6
Hsu, J. C.-N., Hu, P.-A., Chen, C., Lee, C.-J., Hu, H.-Y., Hsu, M., Chen, W., Lee, H., & Lee, T. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101927 · Cited by 7
Nogueira, G., Schwanke, C. H. A., Closs, V. E., Luz, B., Moresco, R. N., Tatsch, E., Bochi, G. V., Moraes, J. F., Jacondino, C. B., Gomes, I., et al. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160401114415 · Cited by 4
Küry, S., Stanton, J. E., van Woerden, G. M., Bosc-Rosati, A., Hsieh, T.-C., Bray, L., Oloudé, M., Rosenfelt, C., Scott-Boyer, M. P., Most, V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65556-8 · Cited by 3
“…of senescent or neurodegenerative cells, including impaired mitophagy 47 , type I IFN response 48 , abnormal apolipoproteins and/or cholesterol levels 49,50 , cognitive in fl exibility 51,52 , impaired neuritogenesis 53,54 , and an imbalanced E/I ratio 55,56 .”
Bin, Y., Zhu, Q., Li, M., & Xia, J. (2019) · IEEE Access · doi:10.1109/access.2019.2935515 · Cited by 3
Lim, S. M., Ng, Y. L., Majeed, A. B. A., Tan, M. P., Khor, H. M., Kamaruzzaman, S. B., & Ramasamy, K. (2024) · GeroScience · doi:10.1007/s11357-024-01462-z · Cited by 3
Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endotheliumPreprint
D'Arrigo, J. S. (2017) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/9afh2 · Cited by 3
Bielawiec, P., Harasim‐Symbor, E., Gołaszewska, K., Chabowski, A., Hodun, K., & Sztolsztener, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315905 · Cited by 2
Rodent Model of Cardiopulmonary Bypass Demonstrates Systemic Inflammation and Neuromarker Changes
Zhang, A. Y., Haywood, N. S., Money, D., Byler, M. R., Osuru, H. P., Atluri, N., Laubach, V. E., Mehaffey, J. H., Charlton, J. R., Lunardi, N., et al. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.09.041 · Cited by 2
Ramadhani, A., Tanaka, A., Minagawa, K., Takehara, S., Yamada, T., Sone, H., Kaneko, N., Nohno, K., & Ogawa, H. (2024) · European Journal of Dentistry · doi:10.1055/s-0044-1795115 · Cited by 2
Treating early dementia: Drug targeting and circumventing the blood-brain barrier
D'Arrigo, J. S. (2018) · Geriatric Medicine and Care · doi:10.15761/gmc.1000111 · Cited by 2
D'Arrigo, J. S. (2019) · SDRP Journal of Nanotechnology & Material Science · doi:10.25177/jnms.2.1.rv.532 · Cited by 2
Decorin is an early CSF biomarker of Alzheimer’s Aβ amyloidosis
Jiang, R., Smailović, U., Haytural, H., Haret, R. M., Shevchenko, G., Tijms, B. M., Gobom, J., Abelein, A., Johansson, J., Zetterberg, H., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.054474 · Cited by 1
D'Arrigo, J. S. (2018) · Preprints.org · doi:10.20944/preprints201808.0204.v1
Nanotherapy for Alzheimer's Disease and Vascular Dementia: Targeting Senile EndotheliumPreprint
D'Arrigo, J. S. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.3041744
Nanotherapy for Early Dementia: Targeting Senile DementiaPreprint
D'Arrigo, J. S. (2017) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3vysu
Wu, J., Cao, L., Wang, J., Wang, Y., Hao, H., & Huang, L. (2022) · Figshare · doi:10.6084/m9.figshare.21268973
Impact of Apolipoprotein A on Cardiac and Neural AbnormalitiesPreprint
Mesilhy, R., Nurulhaque, Z., Burgon, P. G., Pedersen, S., & Al-Saady, R. (2024) · Preprints.org · doi:10.20944/preprints202408.0016.v1
Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · Figshare · doi:10.6084/m9.figshare.13668053
Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · Figshare · doi:10.6084/m9.figshare.13668050
Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · Figshare · doi:10.6084/m9.figshare.13668059
Analyzing Cat Blood Biomarkers Associated with Aging
Marquez, M. A. (2024) · eScholarship (California Digital Library)
Plasma Proteomic Profiling Reveals Divergent Molecular Pathways in Aging and Alzheimer’s DiseasePreprint
Yokogawa, K., Nishioka, T., Nakazawa, S., Ogawa, R., Ikeda, G., Yagishita, H., Miyashita, S., Sashida, G., Kaibuchi, K., Sasaki, T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9815809/v1
Plasma Proteomic Profiling Reveals Divergent Molecular Pathways in Aging and Alzheimer’s DiseasePreprint
Yokogawa, K., Nishioka, T., Nakazawa, S., Ogawa, R., Ikeda, G., Yagishita, H., Miyashita, S., Sashida, G., Kaibuchi, K., Sasaki, T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10007171/v1
Appiah, F., Simpong, D. L., Osei, G. N., Dogah, J., Marfo, E., Antwi, M. H., Donkor, D. M., Manu, K. S., & Bockarie, A. S. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261475263
Metadata
- Authors
- Ma, C., Li, J., Bao, Z., Ruan, Q., & Yu, Z.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Ruan, Qingwei
- Yu, Zhuowei
- Venue
- BioMed Research International
- Publisher
- Hindawi Limited
- Published
- 2015
- Volume
- 2015
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4670907
- OpenAlex
- W2173974781
- Cited by
- 46
- References
- 81
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 7 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 1
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Shanghai Key Laboratory of Clinical Geriatric Medicine Subject Construction (13dz2260700, SHDC12014221)
- Shanghai Hospital Development Center (13dz2260700, SHDC12014221)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- apolipoprotein A-I, apolipoprotein A-II, apolipoprotein C2, serum biomarkers, cognitive impairment, dementia, older men, late-life cognitive decline, interleukin-6, peroxidase, HDL cholesterol, lipid metabolism
- MeSH terms
- Aged, Aged, 80 and over, Cognition, Cognition Disorders, Humans, Lipids, Lipoproteins, HDL, Male, Biomarkers, Interleukin-6, Apolipoprotein A-I, Apolipoprotein A-II, Serum, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.